期刊文献+

骨康胶囊对SaOS-2人成骨样细胞增殖、分化及矿化的影响 被引量:6

Effects of Gukang Capsule on Cell Proliferation,Differentiation and Mineralization of Human Osteoblast-like SaOS-2 Cells
暂未订购
导出
摘要 目的:研究骨康胶囊对体外培养的SaOS-2成骨肉瘤细胞增殖、分化及矿化的影响。方法:培养成骨肉瘤细胞SaOS-2,设立对照组、不同浓度的骨康胶囊组(生药浓度为1、10、100、200、400、800 mg/L)及维生素D3组,采用MTT法检测SaOS-2细胞增殖能力;选择10、100及200 mg/L骨康胶囊浓度处理SaOS-2细胞,对-硝基苯磷酸盐法(PNPP法)检测SaOS-2细胞碱性磷酸酶(ALP)活性,ELISA法检测SaOS-2细胞骨钙素(OTC)和钙离子(Ca^(2+))分泌能力,采用细胞钙茜素红染色法对成骨细胞进行染色、观察SaOS-2细胞矿化能力。结果:与对照组相比,骨康胶囊在体外可以显著促进成骨肉瘤细胞的增殖(P<0.01),当骨康胶囊浓度为200 mg/L时作用最大,此后随着骨康胶囊浓度增大对SaOS-2细胞增殖的促进作用有明显减弱的趋势;在10、100、200 mg/L浓度范围内,骨康胶囊剂量依赖性地增加SaOS-2细胞ALP活性、促进OTC和Ca^(2+)的分泌及细胞矿化结节形成(P<0.05或P<0.01)。结论:骨康胶囊对体外培养的SaOS-2细胞的增殖、分化和矿化有明显的促进作用。 Objective: To study the effects of Gukang capsule on cell proliferation,differentiation and mineralization of human osteoblast-like SaOS-2 cells cultivated in vitro. Methods: SaOS-2 cells were cultivated. The control group,Gukang capsule group with different concentrations( The biological concentrations were 1,10,100,200,400 and 800 mg/L respectively) and Vitamin D3 group were set up,and cell proliferation was tested by MTT assay. The SaOS-2 cells were treated with the Gukang capsule( 10,100 and 200 mg/L respectively),and the Alkaline phosphatase( ALP) activity was measured by PNPP method. Secretion of osteocalcin( OTC) and Ca^2+was detected by ELISA assay.Osteoblasts were stained with calcium alizarin red staining method and mineralization of SaOS-2 cells was observed. Results: Compared with the control group,Gukang capsule could significantly promote proliferation of SaOS-2 cells in vitro( P〈0. 01),and increase ALP activity in a dose-dependent manner( P〈0. 01). Moreover,it could also increase the secretion of OTC and Ca^2+( P〈0. 05,P〈0. 01),and significantly promote the formation of osteoblast mineralization nodules( P〈0. 05).Conclusions: Gukang capsule could increase cell proliferation,differentiation and mineralization activities in SaOS-2 cells cultivated in vitro,which may contribute to its therapeutic effects.
作者 杨健 陆定艳 彭潇 董莉 沈艳珍 李勇军 席晓岚 刘亭 YANG Jian;LU Dingyan;PENG Xiao;DONC Li;SHEN Yanzhen;LI Yongjun;XI Xiaolan;LIU Ting(Guizhou Provincial Key Laboratory of Pharmaceutics / State Key Laboratory of Functions and Applications of Medicinal Plants,Guizhou Medical Ukliversity,Guiyang 550004,Guizhou,China;School of Pharmacy,Guizhou Medical University,Guiyang 550025,Guizhou,China;Engineering Research Center for the Development and Application of Ethnic Medicine and TCM(Ministry of Education),Guizhou Medical University,Guiyang 550004,Guizhou,China;Guizhou Weikang Zifan Pharmaceutical Co.,Ltd,Xiuwen 550200,Guizhou,China)
出处 《贵州医科大学学报》 CAS 2018年第5期517-521,共5页 Journal of Guizhou Medical University
基金 贵州省科技计划项目[黔科合J重大字(2015)2002 黔科合LH字(2016)7373] 贵州省教育厅项目[黔教合重大专项字(2015)040] 贵州省创新人才团队项目[黔科合平台人才(2016)5613 黔科合平台人才(2016)5677]
关键词 骨质疏松症 骨康胶囊 成骨肉瘤细胞 增殖 分化 矿化 碱性磷酸酶 细胞骨钙素 osteoporosis Gukang capsule osteoscarlome cells proliferation differentiation mineralization alkaline phosphata osteocalcin
  • 相关文献

参考文献16

二级参考文献149

共引文献140

同被引文献110

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部